The Winthrop Wound Healing Center is currently investigating a promising new regenerative medicine approach that uses the patient’s own stromal vascular fraction (SVF) cells—a blood component rich in adult stem cells, which can help stimulate the regeneration of healthy tissue. The SVF cells we will be using are obtained from blood vessels in the patient’s adipose (fat) tissue through a process that uses high-frequency ultrasound to break up the fat tissue, then separates out the SVF cells using a centrifuge.
Our wound center is currently working on plans to launch a clinical trial that will evaulate the benefits of using SVF cells to treat non-healing diabetic foot ulcers. In the trial, which will utilize SVF cells supplied by IntelliCell Biosciences, the stem-cell therapy will be administered to patients through a combination of intravenous infusion and topical injection into the wound site. The healing of DFUs and other chronic wounds is just one potential application for SVC-stem cell therapy: It is also being investigated as a possible treatment for osteoarthritis, gum cavity degeneration and multiple sclerosis.